How it works: Inhaled insulin works through the same mechanism as injectable insulin, but it is taken with an oral inhaler rather than through an injection or a pump. The only approved inhaled insulin that is on the market is MannKind’s ultra-rapid-acting inhaled insulin Afrezza.
Who uses it: Inhaled insulin is approved for people with both type 1 and type 2 diabetes. It could be particularly useful for patients with type 2 diabetes who need additional control beyond oral drugs but are not fully comfortable with injections.
In-Depth Article: FDA approved MannKind’s Afrezza – a review of the FDA approval of the inhalable insulin Afrezza, with links to trial results, comments from the medical Advisory Committee, and more.
Coverage of Afrezza's US launch can be found here.
Learn more about how to save on Afrezza here.
Last updated: February 28, 2018